Innoviva Inc (INVA)
15.98
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
15.99
+0.01
(+0.06%)
After-Hours: 20:00
Innoviva Price to Book Value: 1.418 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.418 |
| May 16, 2024 | 1.418 |
| May 15, 2024 | 1.406 |
| May 14, 2024 | 1.430 |
| May 13, 2024 | 1.437 |
| May 10, 2024 | 1.384 |
| May 09, 2024 | 1.357 |
| May 08, 2024 | 1.381 |
| May 07, 2024 | 1.378 |
| May 06, 2024 | 1.371 |
| May 03, 2024 | 1.349 |
| May 02, 2024 | 1.364 |
| May 01, 2024 | 1.352 |
| April 30, 2024 | 1.341 |
| April 29, 2024 | 1.381 |
| April 26, 2024 | 1.356 |
| April 25, 2024 | 1.332 |
| April 24, 2024 | 1.347 |
| April 23, 2024 | 1.348 |
| April 22, 2024 | 1.326 |
| April 19, 2024 | 1.328 |
| April 18, 2024 | 1.305 |
| April 17, 2024 | 1.292 |
| April 16, 2024 | 1.291 |
| April 15, 2024 | 1.285 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.306 |
| April 11, 2024 | 1.313 |
| April 10, 2024 | 1.303 |
| April 09, 2024 | 1.314 |
| April 08, 2024 | 1.314 |
| April 05, 2024 | 1.308 |
| April 04, 2024 | 1.308 |
| April 03, 2024 | 1.322 |
| April 02, 2024 | 1.321 |
| April 01, 2024 | 1.357 |
| March 31, 2024 | |
| March 28, 2024 | 1.428 |
| March 27, 2024 | 1.432 |
| March 26, 2024 | 1.403 |
| March 25, 2024 | 1.414 |
| March 22, 2024 | 1.414 |
| March 21, 2024 | 1.404 |
| March 20, 2024 | 1.386 |
| March 19, 2024 | 1.370 |
| March 18, 2024 | 1.364 |
| March 15, 2024 | 1.392 |
| March 14, 2024 | 1.379 |
| March 13, 2024 | 1.382 |
| March 12, 2024 | 1.388 |
| March 11, 2024 | 1.386 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.258
Minimum
Oct 27 2023
7.832
Maximum
Jun 28 2019
2.728
Average
2.520
Median
Dec 22 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| PE Ratio | 7.198 |
| PS Ratio | 4.118 |
| Price to Free Cash Flow | 8.418 |
| Price | 15.98 |
| Earnings Yield | 13.89% |
| Market Cap | 997.87M |
| Operating PE Ratio | 11.69 |
| Normalized PE Ratio | 7.169 |